{
    "clinical_study": {
        "@rank": "3164", 
        "acronym": "VCD", 
        "arm_group": {
            "arm_group_label": "InSeal's Vascular Closure Device", 
            "arm_group_type": "Experimental", 
            "description": "Use of the experimental VCD to close the access site of the artery"
        }, 
        "brief_summary": {
            "textblock": "The InSeal vascular closure device (VCD)is assessed as percutaneous closure of artery access\n      sites for quick hemostasis and ambulation in patients who have undergone large bore\n      endovascular catheterization procedures.\n\n      The study hypothesis is that the VCD is safe and efficaient in achieving hemostasis in the\n      study population."
        }, 
        "brief_title": "InSeal Vascular Closure Device Clinical Study Protocol", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Percutaneous Closure of Artery Access Sites", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Candidate for large bore catheterization procedure (such as TAVI, aortic endograft\n             repair) using a CE approved 18Fr access sheath.\n\n          -  Subject age is at least 18 years\n\n          -  Patient has signed most recent approved version of the Informed Consent\n\n          -  Existence of an additional arterial access port is required in instances where an\n             occluding balloon is planned to be used as a safety precaution.\n\n        Exclusion Criteria:\n\n          -  Women Of Child Bearing Potential (WOCBP)\n\n          -  Legally non-competent patients\n\n          -  Patient participating in another clinical study at the time of the InSeal VCD study\n\n          -  Prior target artery closure with a vascular closure device having intravascular\n             component (such as Angio-Seal) 30 days prior to catheterization\n\n          -  Subjects with known coagulopathy, preexisting hematoma, arteriovenous fistula, or\n             pseudoaneurysm at the vessel access site prior to artery closure\n\n          -  Patients that do not tolerate aspirin and clopidogrel anticoagulation treatment\n\n          -  Prior vascular surgery or vascular graft in region of access site\n\n          -  Significant calcification, atherosclerotic disease, or stent within 1.5 cm of the\n             puncture site that may interfere with the operation of the experimental device"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01896401", 
            "org_study_id": "13-14-003"
        }, 
        "intervention": {
            "arm_group_label": "InSeal's Vascular Closure Device", 
            "intervention_name": "InSeal's Vascular Closure Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "large bore endovascular catheterization procedures", 
            "Vascular Closure Device"
        ], 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "contact": {
                "email": "horstsievertmd@aol.com", 
                "last_name": "Horst Sievert, Prof.", 
                "phone": "+49 69 9794 7653"
            }, 
            "facility": {
                "address": {
                    "city": "Frankfurt", 
                    "country": "Germany", 
                    "zip": "60389"
                }, 
                "name": "Cardio Vascular Centrum Frankfurt"
            }, 
            "investigator": {
                "last_name": "Horst Sievert, Prof.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "InSeal Vascular Closure Device Clinical Study Protocol", 
        "overall_contact": {
            "email": "horstsievertmd@aol.com", 
            "last_name": "Horst Sievert, Prof.", 
            "phone": "+49 69 9794 7653"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "1. Hemostasis within  15 minutes following vessel access site closure and after ACT falls below 200 second", 
            "safety_issue": "No", 
            "time_frame": "15 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01896401"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "2. Combined rate of closure-device related major adverse events in first month", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "source": "InSeal Medical Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "InSeal Medical Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}